单位:[1]Graduate School, Beijing University of Chinese Medicine, Beijing 100029, China[2]Oncology Department, Wangjing Hospital of China Academy of Chinese Medical Sciences, Beijing 100102, China[3]Department of Acupuncture and Moxibustion, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing Key Laboratory of Acupuncture[4]Department of Integrative Oncology, China-Japan Friendship Hospital, Beijing 100029, China[5]Key Laboratory of Growth Regulation and Translational Research of Zhejiang Province, School of Life Sciences, Westlake University, Zhejiang 310024, China[6]School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China[7]Clinical Research Center, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai[8]Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna 17165, Sweden[9]Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Solna 17165, Sweden[10]School of Biological Sciences, Nanyang Technological University, Singapore 637551, Singapore[11]Department of Microbiology, Tumor, and Cell Biology (MTC), Karolinska Institutet, Stockholm 17177, Sweden
第一作者单位:[1]Graduate School, Beijing University of Chinese Medicine, Beijing 100029, China[2]Oncology Department, Wangjing Hospital of China Academy of Chinese Medical Sciences, Beijing 100102, China
共同第一作者:
通讯作者:
通讯机构:[10]School of Biological Sciences, Nanyang Technological University, Singapore 637551, Singapore[11]Department of Microbiology, Tumor, and Cell Biology (MTC), Karolinska Institutet, Stockholm 17177, Sweden[*1]School of Biological Sciences, Nanyang Technological University, Singapore 637551, Singapore.
推荐引用方式(GB/T 7714):
Xie Feiyu,Wang Mina,Chen Qishuang,et al.Endogenous Stimuli-Responsive Nanoparticles for Cancer Therapy: From Bench to Bedside[J].Pharmacological Research.2022,106522.doi:10.1016/j.phrs.2022.106522.
APA:
Xie Feiyu,Wang Mina,Chen Qishuang,Chi Tiange,Zhu Shijie...&Liao Zehuan.(2022).Endogenous Stimuli-Responsive Nanoparticles for Cancer Therapy: From Bench to Bedside.Pharmacological Research,,
MLA:
Xie Feiyu,et al."Endogenous Stimuli-Responsive Nanoparticles for Cancer Therapy: From Bench to Bedside".Pharmacological Research .(2022):106522